Baseline Antithrombotic Therapy and Intracranial Hemorrhage Risk in Infective Endocarditis: A Multicenter Prospective Cohort Study
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciag067 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Javier T Solera und 15 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Infectious Diseases, Hospital Universitario 12 de Octubre, Instituto de Investigación Biomédica imas12, Madrid, Spain. Hauptthemen laut MEDLINE: Intracranial Hemorrhages, Endocarditis, Fibrinolytic Agents. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Infective endocarditis (IE) carries high morbidity and mortality, largely from neurological complications. The clinical significance of chronic antithrombotic therapy remains uncertain. We assessed whether baseline antithrombotic therapy influences intracranial hemorrhage (ICH) and mortality in left-sided IE.
Methods
We analyzed a prospective multicenter cohort (2008–2018) including all patients with definite left-sided IE. Patients were classified at diagnosis as receiving no therapy (NT), antiplatelet therapy (APT), anticoagulation (AC), or combined therapy (CAT). The primary outcome was 30-day ICH; secondary outcomes included ischemic stroke, embolic events, major bleeding, and all-cause mortality. Multivariable logistic and Cox regression models adjusted for confounders.
Results
Among 3236 patients, 182 (5.6%) developed ICH, with the highest incidence in CAT (9.5%) and AC (6.8%). Compared with NT, baseline AC was independently associated with a higher frequency of ICH (adjusted risk ratio [aRR] 1.83, 95% CI 1.16–2.91), with the highest risk observed in CAT (aRR 2.45, 95% CI 1.55–3.87). Antiplatelet therapy was not associated with ICH. Ischemic stroke rates were similar across groups. Combined anticoagulation and antiplatelet therapy independently predicted higher 1-year mortality (adjusted hazard ratio [aHR] 1.21, 95% CI 1.02–1.43). Independent factors associated with ICH were Staphylococcus aureus and Candida spp. IE, extracranial embolism, prior cerebrovascular disease, and septic shock.
Conclusions
These findings highlight the value of baseline antithrombotic exposure, together with microbiologic etiology and prior cerebrovascular disease, for early neurologic risk stratification at the time of IE diagnosis, informing neuroimaging decisions and multidisciplinary discussions involving infectious diseases specialists, neurologist, and cardiac surgeons among other specialists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Infectious Diseases, Hospital Universitario 12 de Octubre, Instituto de Investigación Biomédica imas12, Madrid, Spain.
- Cardiology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación Biomédica imas12, Madrid, Spain.
- Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias-CIBERES (CB06/06/0058), Madrid, Spain.
- Medicine Department, Universidad Complutense de Madrid, Madrid, Spain.
- Neurology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
ORCID-Profile: Javier T Solera, Patricia Muñoz, Ana Álvarez-Uría Miyares, M Carmen Fariñas, José M Miró, Miguel Ángel Goenaga-Sánchez, Francisco López-Medrano
Zitieren
APA
Solera, J. T., Aparicio-Minguijón, E., Domínguez-Pérez, L., Muñoz, P., Vázquez-Alen, P., Miyares, A. Á., de Alarcón, A., Poyato-Borrego, M., Fariñas, M. C., Miró, J. M., Goenaga-Sánchez, M. Á., Ojeda-Burgos, G., López-Cortés, L. E., Sousa-Regueiro, D., López-Medrano, F., & GAMES Investigators (2026). Baseline Antithrombotic Therapy and Intracranial Hemorrhage Risk in Infective Endocarditis: A Multicenter Prospective Cohort Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag067
Vancouver
Solera JT, Aparicio-Minguijón E, Domínguez-Pérez L, Muñoz P, Vázquez-Alen P, Miyares AÁ, et al. Baseline Antithrombotic Therapy and Intracranial Hemorrhage Risk in Infective Endocarditis: A Multicenter Prospective Cohort Study. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag067
BibTeX
@article{Solera2026,
author = {Solera, Javier T and Aparicio-Minguijón, Eduardo and Domínguez-Pérez, Laura and Muñoz, Patricia and Vázquez-Alen, Pilar and Miyares, Ana Álvarez-Uría and de Alarcón, Arístides and Poyato-Borrego, Manuel and Fariñas, M Carmen and Miró, José M and Goenaga-Sánchez, Miguel Ángel and Ojeda-Burgos, Guillermo and López-Cortés, Luis Eduardo and Sousa-Regueiro, Dolores and López-Medrano, Francisco and GAMES Investigators, GAMES Investigators},
title = {Baseline Antithrombotic Therapy and Intracranial Hemorrhage Risk in Infective Endocarditis: A Multicenter Prospective Cohort Study},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag067}
}
EUVIMED